13G Filing: VenBio Select Advisor and Mirati Therapeutics Inc. (MRTX)

Page 3 of 7 – SEC Filing

1

NAME OF REPORTING PERSON

Behzad Aghazadeh

2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a) ¨

(b) þ

3 SEC USE ONLY
4

CITIZENSHIP OR PLACE OF ORGANIZATION

United States

NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH:
5

SOLE VOTING POWER

3,748,101 (including 37,500 shares of Common Stock
issuable upon exercise of Warrants)

6

SHARED VOTING POWER

0

7

SOLE DISPOSITIVE POWER

3,748,101 (including 37,500 shares of Common Stock
issuable upon exercise of Warrants)

8

SHARED DISPOSITIVE POWER

0

9

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

3,748,101 (including 37,500 shares of Common Stock
issuable upon exercise of Warrants)

10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES ¨
11

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

14.99%

12

TYPE OF REPORTING PERSON

IN

Follow Mirati Therapeutics Inc. (NASDAQ:MRTX)